poisar

Stocks · News reference

MOH stock has given up its prior loss. Molina Healthcare shares were trading lower after Wells Fargo lowered its price target on the stock from $235 to $220.

Benzinga Newsdesk
More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

MOH
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Zacks.Com

    Analysts Estimate Molina (MOH) to Report a Decline in Earnings: What to Look Out for

    Molina Healthcare is expected to report a significant year-over-year earnings decline of 60.9% to $0.72 per share for Q3 2026, with revenues down 4.8% to $10.93 billion. The stock carries a Zacks Rank #4 (Sell) with a negative Earnings ESP of -3.30%, making it unlikely to beat consensus estimates. While the company has beaten estimates in 2 of the last 4 quarters, current analyst sentiment has turned bearish with recent estimate revisions.

    MOH
  3. Na

    Can Oscar Health Turn ACA Marketplace Growth Into Lasting Profits?

    Oscar Health (OSCR) has surged 130% year-to-date driven by ACA marketplace expansion and plans to enter 150+ metro areas by 2027. However, the stock trades at a premium 4.94 price-to-book ratio versus the industry average of 2.64, and long-term profitability depends on disciplined underwriting and cost management rather than favorable policy conditions alone. Concentration risk from ACA exposure and potential subsidy policy changes pose headwinds.

    OSCRMOHCNC
  4. Na

    Oscar Health Trading at a Premium: Why Should You Still Buy It?

    Oscar Health (OSCR) trades at a premium valuation of 4.65x book value but has gained 142.5% year-to-date, driven by strong membership growth to 2.96 million, 70% revenue surge to $4.88 billion in Q2, and improved profitability. The company targets 20% revenue CAGR through 2027 and 5% operating margin next year, supported by its technology-driven platform and expansion into 150+ new metropolitan areas. Analysts maintain optimistic sentiment with upward earnings estimate revisions.

    OSCRMOHCNC